Genetically modified animals for use in bio‑pharmacology: from research to production as bioreactors for the pharmaceutical industry of
a new type. The necessity of improving the technology
Retinal damage in amyotrophic lateral sclerosis: underlying mechanismsAmyotrophic lateral sclerosis (ALS) is
a fatal neurodegenerative disease resulting in
a gradual
Gene therapy approach for treatment of obese agouti miceYunin, M.A.,
Boychenko, S.S.,
Lebedev, P.,
Deykin, A.V.,
Pokrovskii, M.V.,
Egorov, A.D. In this study, we explored
a gene therapy approach to treat obesity in agouti mice using adeno
Cytokines in abdominal aortic aneurysm: master regulators with clinical applicationAbdominal aortic aneurysm (AAA) is
a potentially life-threatening disorder with
a mostly
On the way from SARS-CoV-sensitive mice to murine COVID-19 modelThe coronavirus disease 2019 (COVID-19) is
a master killer which appeared suddenly and which has
On the way from SARS-CoV-sensitive mice to murine COVID-19 modelThe coronavirus disease 2019 (COVID-19) is
a master killer which appeared suddenly and which has
Neurokinin-1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodesKokhan, V. S.,
Anokhin, P. K.,
Abaimov, D. A.,
Shamakina, I. Yu.,
Soldatov, V. O.,
Deykin, A. V. findings suggest that rolapitant should be further investigated as
a novel treatment option for relapse
Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] geneThe aim of this work was to assess the structural and functional state of the retina in
a murine